vs
Side-by-side financial comparison of iQSTEL Inc (IQST) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.
OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $84.2M, roughly 1.8× iQSTEL Inc). iQSTEL Inc runs the higher net margin — -3.2% vs -21.1%, a 17.9% gap on every dollar of revenue. On growth, iQSTEL Inc posted the faster year-over-year revenue change (-14.9% vs -19.2%). iQSTEL Inc produced more free cash flow last quarter ($-1.2M vs $-28.6M). Over the past eight quarters, iQSTEL Inc's revenue compounded faster (28.0% CAGR vs -7.5%).
iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
IQST vs OPK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $84.2M | $148.5M |
| Net Profit | $-2.7M | $-31.3M |
| Gross Margin | 3.5% | 43.1% |
| Operating Margin | -2.9% | -25.8% |
| Net Margin | -3.2% | -21.1% |
| Revenue YoY | -14.9% | -19.2% |
| Net Profit YoY | -44.5% | -322.8% |
| EPS (diluted) | $-0.92 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $84.2M | $148.5M | ||
| Q3 25 | $102.9M | $151.7M | ||
| Q2 25 | $72.2M | $156.8M | ||
| Q1 25 | $57.6M | $150.0M | ||
| Q4 24 | $98.9M | $183.6M | ||
| Q3 24 | $54.2M | $173.6M | ||
| Q2 24 | $78.6M | $182.2M | ||
| Q1 24 | $51.4M | $173.7M |
| Q4 25 | $-2.7M | $-31.3M | ||
| Q3 25 | $-2.3M | $21.6M | ||
| Q2 25 | $-2.3M | $-148.4M | ||
| Q1 25 | $-1.1M | $-67.6M | ||
| Q4 24 | $-1.9M | $14.0M | ||
| Q3 24 | $-773.0K | $24.9M | ||
| Q2 24 | $-2.0M | $-10.3M | ||
| Q1 24 | $-580.2K | $-81.8M |
| Q4 25 | 3.5% | 43.1% | ||
| Q3 25 | 2.7% | 32.9% | ||
| Q2 25 | 2.6% | 31.5% | ||
| Q1 25 | 3.4% | 28.4% | ||
| Q4 24 | 2.7% | 46.1% | ||
| Q3 24 | 3.7% | 23.1% | ||
| Q2 24 | 2.8% | 28.4% | ||
| Q1 24 | 2.7% | 24.2% |
| Q4 25 | -2.9% | -25.8% | ||
| Q3 25 | -0.5% | 31.7% | ||
| Q2 25 | -0.9% | -38.3% | ||
| Q1 25 | -1.0% | -44.8% | ||
| Q4 24 | -0.3% | -18.0% | ||
| Q3 24 | -0.1% | 8.2% | ||
| Q2 24 | -0.4% | -33.9% | ||
| Q1 24 | -0.4% | -41.2% |
| Q4 25 | -3.2% | -21.1% | ||
| Q3 25 | -2.3% | 14.3% | ||
| Q2 25 | -3.3% | -94.7% | ||
| Q1 25 | -2.0% | -45.1% | ||
| Q4 24 | -1.9% | 7.6% | ||
| Q3 24 | -1.4% | 14.3% | ||
| Q2 24 | -2.5% | -5.7% | ||
| Q1 24 | -1.1% | -47.1% |
| Q4 25 | $-0.92 | $-0.04 | ||
| Q3 25 | $-0.68 | $0.03 | ||
| Q2 25 | $-0.82 | $-0.19 | ||
| Q1 25 | $-0.44 | $-0.10 | ||
| Q4 24 | $-1.19 | $0.02 | ||
| Q3 24 | $-0.40 | $0.03 | ||
| Q2 24 | $-0.90 | $-0.01 | ||
| Q1 24 | $-0.37 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2M | $364.4M |
| Total DebtLower is stronger | $4.1M | $344.0M |
| Stockholders' EquityBook value | $16.3M | $1.3B |
| Total Assets | $51.1M | $1.9B |
| Debt / EquityLower = less leverage | 0.25× | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2M | $364.4M | ||
| Q3 25 | $2.3M | $412.0M | ||
| Q2 25 | $2.0M | $267.3M | ||
| Q1 25 | $1.1M | $428.8M | ||
| Q4 24 | $2.5M | $426.6M | ||
| Q3 24 | $2.1M | $400.1M | ||
| Q2 24 | $797.2K | $40.6M | ||
| Q1 24 | $2.7M | $75.6M |
| Q4 25 | $4.1M | $344.0M | ||
| Q3 25 | $2.7M | $344.2M | ||
| Q2 25 | $4.5M | $343.3M | ||
| Q1 25 | $3.5M | $439.2M | ||
| Q4 24 | $2.5M | $437.2M | ||
| Q3 24 | $3.2M | $441.0M | ||
| Q2 24 | $2.5M | $201.9M | ||
| Q1 24 | $194.0K | $350.1M |
| Q4 25 | $16.3M | $1.3B | ||
| Q3 25 | $17.9M | $1.3B | ||
| Q2 25 | $14.3M | $1.3B | ||
| Q1 25 | $11.6M | $1.3B | ||
| Q4 24 | $11.9M | $1.4B | ||
| Q3 24 | $8.1M | $1.4B | ||
| Q2 24 | $7.6M | $1.4B | ||
| Q1 24 | $8.4M | $1.3B |
| Q4 25 | $51.1M | $1.9B | ||
| Q3 25 | $46.9M | $2.0B | ||
| Q2 25 | $51.4M | $2.0B | ||
| Q1 25 | $42.0M | $2.1B | ||
| Q4 24 | $79.0M | $2.2B | ||
| Q3 24 | $32.4M | $2.3B | ||
| Q2 24 | $30.0M | $2.0B | ||
| Q1 24 | $22.1M | $2.0B |
| Q4 25 | 0.25× | 0.27× | ||
| Q3 25 | 0.15× | 0.26× | ||
| Q2 25 | 0.31× | 0.26× | ||
| Q1 25 | 0.31× | 0.33× | ||
| Q4 24 | 0.21× | 0.32× | ||
| Q3 24 | 0.40× | 0.31× | ||
| Q2 24 | 0.34× | 0.14× | ||
| Q1 24 | 0.02× | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | $-25.9M |
| Free Cash FlowOCF − Capex | $-1.2M | $-28.6M |
| FCF MarginFCF / Revenue | -1.5% | -19.3% |
| Capex IntensityCapex / Revenue | 0.0% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-4.0M | $-190.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2M | $-25.9M | ||
| Q3 25 | $-953.0K | $-34.6M | ||
| Q2 25 | $257.7K | $-83.4M | ||
| Q1 25 | $-1.9M | $-34.6M | ||
| Q4 24 | $-403.7K | $-44.4M | ||
| Q3 24 | $625.0K | $-77.1M | ||
| Q2 24 | $-2.6M | $-26.4M | ||
| Q1 24 | $-536.9K | $-35.6M |
| Q4 25 | $-1.2M | $-28.6M | ||
| Q3 25 | $-969.2K | $-37.8M | ||
| Q2 25 | $211.7K | $-86.7M | ||
| Q1 25 | $-2.0M | $-37.7M | ||
| Q4 24 | $-421.3K | $-49.8M | ||
| Q3 24 | $594.5K | $-85.0M | ||
| Q2 24 | $-2.6M | $-33.7M | ||
| Q1 24 | $-608.5K | $-40.0M |
| Q4 25 | -1.5% | -19.3% | ||
| Q3 25 | -0.9% | -24.9% | ||
| Q2 25 | 0.3% | -55.3% | ||
| Q1 25 | -3.4% | -25.2% | ||
| Q4 24 | -0.4% | -27.1% | ||
| Q3 24 | 1.1% | -49.0% | ||
| Q2 24 | -3.4% | -18.5% | ||
| Q1 24 | -1.2% | -23.0% |
| Q4 25 | 0.0% | 1.8% | ||
| Q3 25 | 0.0% | 2.1% | ||
| Q2 25 | 0.1% | 2.1% | ||
| Q1 25 | 0.1% | 2.1% | ||
| Q4 24 | 0.0% | 2.9% | ||
| Q3 24 | 0.1% | 4.6% | ||
| Q2 24 | 0.0% | 4.0% | ||
| Q1 24 | 0.1% | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.60× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.17× | ||
| Q3 24 | — | -3.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
